E protein targets orchestrating γδ development and function
E protein targets orchestrating γδ development and function
批准号:
10685626
负责人:
DAVID L. WIEST
金额:
$14.73万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-15 至 2024-07-31
关键词:
AblationAddressAdoptionAffectBindingBinding ProteinsBinding SitesCCR6 geneCD8B1 geneCell LineageCell MaturationCellsDNA-Binding ProteinsDevelopmentDiseaseElementsFamily memberGene TargetingGenetic TranscriptionGenomeGenomicsHDAC1 geneHealthHost DefenseHumanIL17 geneImmuneImmune responseIndividualKnowledgeLinkMediatingMolecularMutant Strains MiceMutationPathologicPathologyPlayProcessProteinsReceptor SignalingRegulationRegulatory ElementRepressionResearchRoleSignal TransductionSiteSpecific qualifier valueT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTCF Transcription FactorTCF3 geneTestingThymus GlandTransgenic MiceUntranslated RNAgenome-widegenome-wide analysisinsightnovelpreservationprogenitorprogramsstem cellsthymocytetumor progressionγδ T cells
中文摘要
项目摘要/摘要
T淋巴细胞包括两个主要的谱系,和,它们在宿主防御中发挥着关键的、部分不同的作用。
和T细胞来自胸腺中共同的祖细胞;然而,负责的分子过程
对于胸腺发育过程中这些血统的规范仍然不清楚,这代表了一个主要的
知识上的差距。我们寻求解决这一知识鸿沟。通过这样做,我们提供了令人信服的证据
和T细胞命运的指定受T细胞受体信号强度的差异控制。
这些信号差异通过ID3的比例诱导来调节命运,ID3导致对
E盒DNA结合蛋白(E蛋白;E2a和Heb)的功能。为了深入了解E蛋白是如何与
基因组在命运规范期间被重塑,我们(所有项目)采用了全面的、全基因组的
这一方法揭示了一些重要的见解。第一,E蛋白家族成员的抑制
强的TCR信号是选择性的,因为E2a与基因组的结合被显著抑制,而Heb结合被
保留(所有项目)。重要的是,保留Heb绑定似乎很重要,就像Heb功能一样
产生IL-17的T细胞的发育所需(项目1/3/4)。第二,E蛋白结合紧密
与非编码转录相关,包括长的非编码RNA(lncRNA;所有项目)。事实上,我们
(项目1和4)证明了这样一种名为ThymoD的lncRNA在T细胞谱系中起着重要作用。
承诺。最后,在由E蛋白占据的众多调控元件中,
在谱系承诺期间进行调节,我们已经确定了在控制方面发挥关键作用的两个
发展和功能。事实上,E蛋白与控制细胞周期的调控元件结合的中断
转录因子TCF7或LncRNAGm15417的表达促进T细胞成熟并促进
采用产生IL-17的效应器命运。因此,在目前的提案中,我们将所有这些整合在一起
阐明E蛋白与这些元件结合的变化控制的机制基础的见解
产生IL-17的T细胞的研制IL-17产生的发育控制因素研究
T细胞是至关重要的,因为这些细胞与许多免疫介导的病理和癌症有关。
进步。要执行这项研究计划,我们完全依赖项目负责人的专业知识
在该计划中,以及基因组学核心B。这一努力有望提供对E的作用的更大洞察力
蛋白质控制的发育和功能,这对人类健康和
疾病。
英文摘要
PROJECT SUMMARY/ABSTRACT
T lymphocytes comprise two major lineages, and , which play critical, partially-distinct roles in host defense.
and T cells arise from a common progenitor in the thymus; however, the molecular processes responsible
for specification of these lineages during development in the thymus remain unclear and this represents a major
gap in knowledge. We seek to address this knowledge gap. In doing so, we have provided compelling evidence
that specification of the and T cell fates is controlled by differences in T cell receptor (TCR) signal strength.
These signaling differences regulate fate by proportional induction of Id3, which causes graded repression of the
function of E box DNA binding proteins (E proteins; E2A and HEB). To gain insight into how E protein binding to
the genome is remodeled during fate specification, we (all Projects) employed a comprehensive, genome-wide
approach, which revealed a number of important insights. First, the repression of E protein family members by
strong TCR signals is selective, in that E2A binding to the genome is markedly repressed, while HEB binding is
preserved (all Projects). Importantly, the sparing of HEB binding appears to be important, as HEB function is
required for development of T cells that produce IL-17 (Proj1/3/4). Second, E protein binding is closely
associated with non-coding transcription, including long non-coding RNAs (lncRNA; all Projects). Indeed, we
(Projects 1 and 4) demonstrated that one such lncRNA, ThymoD, plays an essential role in T lineage
commitment. Finally, from among the numerous regulatory elements whose occupancy by E proteins is
modulated during lineage commitment, we have already identified two that play critical roles in controlling
development and function. Indeed, disruption of E protein binding to regulatory elements controlling the
expression of either transcription factor Tcf7 or lncRNA Gm15417 enhances T cell maturation and promotes
adoption of the IL-17 producing effector fate. Consequently, in the current proposal, we integrate all of these
insights to elucidate the mechanistic basis by which changes in E protein binding to these elements controls
development of IL-17 producing T cells. Insight into the factors controlling development of IL-17 producing
T cells is critical, as these cells have been implicated in numerous immune-mediated pathologies and cancer
progression. To execute this research plan, we are entirely dependent upon the expertise of the Project Leaders
in the program, as well as Genomics Core B. This effort promises to provide great insight into the role of E
proteins in controlling both development and function, which is of critical importance to human health and
disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Analysis of Variants Underlying T Cell Defects
-
批准号:10024573
-
项目类别:
-
资助金额:$48.95万
-
财政年份:2020
-
负责人:DAVID L. WIEST
-
依托单位:
Functional Analysis of Variants Underlying T Cell Defects
-
批准号:10462634
-
项目类别:
-
资助金额:$51.77万
-
财政年份:2020
-
负责人:DAVID L. WIEST
-
依托单位:
ThymUS 2020 International Conference on Lymphopoiesis
-
批准号:9913243
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2020
-
负责人:DAVID L. WIEST
-
依托单位:
Functional Analysis of Variants Underlying T Cell Defects
-
批准号:10256631
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2020
-
负责人:DAVID L. WIEST
-
依托单位:
The ThymUS 2016 International Conference on Lymphopoiesis
-
批准号:8986580
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2016
-
负责人:DAVID L. WIEST
-
依托单位:
Regulation of Hematopoiesis by Ribosomal Protein Paralogs
-
批准号:8816656
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2015
-
负责人:DAVID L. WIEST
-
依托单位:
Molecular Basis for gamma/delta T Lineage Specification
-
批准号:8608275
-
项目类别:
-
资助金额:$186.17万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Regulation of Hematopoiesis By Ribosomal Protein Paralogs
-
批准号:8880580
-
项目类别:
-
资助金额:$44.63万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Administrative Core
-
批准号:8608280
-
项目类别:
-
资助金额:$10.47万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Regulation of hematopoiesis by ribosomal protein paralogs
-
批准号:10548846
-
项目类别:
-
资助金额:$56.1万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Influence of ligand on specification of gamma/delta fate and function
-
批准号:8608276
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Molecular basis of γδ T lineage specification
-
批准号:10226992
-
项目类别:
-
资助金额:$200.43万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Regulation of hematopoiesis by ribosomal protein paralogs
-
批准号:10333363
-
项目类别:
-
资助金额:$56.1万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Molecular basis of γδ T lineage specification
-
批准号:10685621
-
项目类别:
-
资助金额:$198.09万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
E protein targets orchestrating γδ development and function
-
批准号:10462547
-
项目类别:
-
资助金额:$58.37万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Administrative Core
-
批准号:10462545
-
项目类别:
-
资助金额:$16.76万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Administrative Core
-
批准号:10685622
-
项目类别:
-
资助金额:$21.39万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Molecular basis of γδ T lineage specification
-
批准号:9793218
-
项目类别:
-
资助金额:$214.45万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Administrative Core
-
批准号:10226993
-
项目类别:
-
资助金额:$13.29万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
Molecular Basis for gamma/delta T Lineage Specification
-
批准号:8849346
-
项目类别:
-
资助金额:$183.05万
-
财政年份:2014
-
负责人:DAVID L. WIEST
-
依托单位:
海外基金